Levetiracetam

In the US, Levetiracetam (levetiracetam systemic) is a member of the drug class pyrrolidine anticonvulsants and is used to treat Bipolar Disorder, Epilepsy, Hyperekplexia, Neuralgia, New Daily Persistent Headache and Seizures.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N03AX14

CAS registry number (Chemical Abstracts Service)

0102767-28-2

Chemical Formula

C8-H14-N2-O2

Molecular Weight

170

Therapeutic Categories

Antiepileptic agent

Pyrrolidone derivative

Chemical Names

(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide (WHO)

1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (S)-

Foreign Names

  • Levetiracetamum (Latin)
  • Levetiracetam (German)
  • Lévétiracétam (French)
  • Levetiracetam (Spanish)

Generic Names

  • Levetiracetam (OS: USAN, BAN)
  • Lévétiracétam (OS: DCF)
  • Levetiracetam (PH: Ph. Eur. 7, USP 34)
  • Levetiracetamum (PH: Ph. Eur. 7)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)